The molecular targets of approved treatments for pulmonary arterial hypertension

por Humbert, Marc, Ghofrani, Hossein-Ardeschir
Publicado 2016

Modulating cGMP to Treat Lung Diseases

por Ghofrani, Hossein-Ardeschir, Grimminger, Friedrich
Publicado 2009

The role of combination therapy in managing pulmonary arterial hypertension

por Ghofrani, Hossein-Ardeschir, Humbert, Marc
Publicado 2014

Medical management of chronic thromboembolic pulmonary hypertension

por Pepke-Zaba, Joanna, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M.
Publicado 2017

Analysis of Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Balloon Pulmonary Angiopl...

por Ley, Lukas, Wiedenroth, Christoph B., Ghofrani, Hossein Ardeschir, Hoeltgen, Reinhard, Bandorski, Dirk
Publicado 2023

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension

por Grimminger, Jan, Richter, Manuel, Tello, Khodr, Sommer, Natascha, Gall, Henning, Ghofrani, Hossein Ardeschir
Publicado 2017

Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension

por Bandorski, Dirk, Heibel, Sebastian, Höltgen, Reinhard, Bogossian, Harilaos, Ghofrani, Hossein Ardeschir, Zarse, Markus, Gall, Henning
Publicado 2023

Quality of life in patients with chronic thromboembolic pulmonary hypertension

por Mathai, Stephen C., Ghofrani, Hossein-Ardeschir, Mayer, Eckhard, Pepke-Zaba, Joanna, Nikkho, Sylvia, Simonneau, Gérald
Publicado 2016

Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies

por Cartin-Ceba, Rodrigo, Halank, Michael, Ghofrani, Hossein-Ardeschir, Humbert, Marc, Mattson, John, Fritsch, Arno, Krowka, Michael
Publicado 2018

Reply to Bogaard et al.: Emphysema Is—at the Most—Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension

por Kojonazarov, Baktybek, Hadzic, Stefan, Ghofrani, Hossein Ardeschir, Grimminger, Friedrich, Seeger, Werner, Weissmann, Norbert, Schermuly, Ralph Theo
Publicado 2019

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors

por Schermuly, Ralph Theo, Inholte, Christiane, Ghofrani, Hossein Ardeschir, Gall, Henning, Weissmann, Norbert, Weidenbach, Andreas, Seeger, Werner, Grimminger, Friedrich
Publicado 2005

Effects of riociguat in severe experimental pulmonary hypertension

por Kojonazarov, Baktybek, Lang, Michaela, Weissmann, Norbert, Grimminger, Friedrich, Stasch, Johannes-Peter, Seeger, Werner, Ghofrani, Hossein Ardeschir, Schermuly, Ralph
Publicado 2011

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats

por Lang, Michaela, Kojonazarov, Baktybek, Weissmann, Norbert, Grimminger, Friedrich, Stasch, Johannes-Peter, Seeger, Werner, Ghofrani, Hossein Ardeschir, Schermuly, Ralph
Publicado 2011

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial

por Richter, Manuel J., Stollfuß, Barbara, Roitenberg, Alexander, Kleinjung, Frank, Graeff , Valentin, Berghaus, Sabine, Müller, Christian, Ghofrani, Hossein-Ardeschir
Publicado 2018

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

por Humbert, Marc, Farber, Harrison W., Ghofrani, Hossein-Ardeschir, Benza, Raymond L., Busse, Dennis, Meier, Christian, Hoeper, Marius M.
Publicado 2019

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

por Lang, Irene, Meyer, Bernhard C., Ogo, Takeshi, Matsubara, Hiromi, Kurzyna, Marcin, Ghofrani, Hossein-Ardeschir, Mayer, Eckhard, Brenot, Philippe
Publicado 2017

Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension

por Tiede, Henning, Rorzyczka, Janet, Dumitrascu, Rio, Belly, Michael, Reichenberger, Frank, Ghofrani, Hossein Ardeschir, Seeger, Werner, Heitmann, Jörg, Schulz, Richard
Publicado 2015

Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies

por Stephan, Rosenkranz, Ghofrani, Hossein-Ardeschir, Beghetti, Maurice, Ivy, Dunbar, Fritsch, Arno, Weimann, Gerrit, Saleh, Soundos, Apitz, Christian, Frey, Reiner
Publicado 2015

Riociguat for pulmonary arterial hypertension associated with congenital heart disease

por Rosenkranz, Stephan, Ghofrani, Hossein-Ardeschir, Beghetti, Maurice, Ivy, Dunbar, Frey, Reiner, Fritsch, Arno, Weimann, Gerrit, Saleh, Soundos, Apitz, Christian
Publicado 2015

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

por Richter, Manuel Jonas, Tiede, Svenja Lena, Sommer, Natascha, Schmidt, Thomas, Seeger, Werner, Ghofrani, Hossein Ardeschir, Schermuly, Ralph, Gall, Henning
Publicado 2016